|
|
Volumn 30, Issue 3, 2009, Pages 219-225
|
|
Diagnostics and therapy of AA amyloidosis;Diagnostik und Therapie der AA-Amyloidose
|
|
Author keywords
Amyloidosis; Colchicine; Familial Mediterranean fever; Rheumatic disease; TNF
|
|
Indexed keywords
ABATACEPT;
ADALIMUMAB;
ATLIZUMAB;
C REACTIVE PROTEIN;
CANAKINUMAB;
CERTOLIZUMAB PEGOL;
COLCHICINE;
CRYOPYRIN;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
EPRODISATE;
ETANERCEPT;
GOLIMUMAB;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INFLIXIMAB;
INTERLEUKIN 1BETA;
INTERLEUKIN 1BETA ANTIBODY;
MONOCLONAL ANTIBODY;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RILONACEPT;
RITUXIMAB;
SERUM AMYLOID A;
STEROID;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
UNCLASSIFIED DRUG;
AMYLOIDOSIS;
ARTICLE;
AUTOIMMUNE DISEASE;
BLAU SYNDROME;
CHRONIC DISEASE;
CINCA SYNDROME;
DIFFERENTIAL DIAGNOSIS;
DISEASE ASSOCIATION;
DISEASE COURSE;
FAMILIAL MEDITERRANEAN FEVER;
GASTROINTESTINAL DISEASE;
GENE MUTATION;
HEART AMYLOIDOSIS;
HUMAN;
HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME;
INFECTION;
KIDNEY AMYLOIDOSIS;
LUNG DISEASE;
MUCKLE WELLS SYNDROME;
PAPA SYNDROME;
PREVALENCE;
PROGNOSIS;
RECURRENT FEVER;
RHEUMATIC DISEASE;
RHEUMATOID ARTHRITIS;
SARCOIDOSIS;
TUBERCULOSIS;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;
URTICARIA;
AMYLOIDOSIS;
DISEASE PROGRESSION;
FAMILIAL MEDITERRANEAN FEVER;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
INTERLEUKIN-1BETA;
LUNG DISEASES;
NEPHRITIS;
RHEUMATIC DISEASES;
RISK FACTORS;
SERUM AMYLOID A PROTEIN;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 67549143925
PISSN: 01728113
EISSN: None
Source Type: Journal
DOI: 10.1007/s00292-009-1140-5 Document Type: Article |
|
Times cited : (6)
|
|
References (30)
|
